Sanofi Genzyme forms multiple sclerosis research collaboration with Johns Hopkins School of Medicine
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of Medicine that will focus on novel strategies aimed at advancing the understanding of underlying causes of disease progression in multiple sclerosis (MS).
Click on this link for more information.
